Why did TMD.TO stock spike intraday on 20 Feb 2026?

The spike was driven by heavy trading in a normally thinly traded name, with **117,220** shares versus an average of **45,936**. No major earnings release was filed; the move likely reflects speculative flow, liquidity shocks, or accumulation by large holders.

What valuation metrics matter for Titan Medical (TMD.TO)?

Key metrics include market cap **C$128.30M**, price-to-sales around **5.32**, price-to-book near **19.44**, EPS **-1.73**, and current ratio **2.78**. High multiples vs. book indicate price is driven by future expectations, increasing valuation risk.

How should traders approach TMD.TO stock after today’s volume surge?

Use strict risk controls, limit position size, and wait for confirmation from follow-through volume or company news. Given thin historical liquidity, expect sharp reversals and wide spreads; day traders should set firm stops.

What does Meyka AI forecast for TMD.TO stock?

Meyka AI's forecast model projects **C$0.85** in six months, implying **-24.44%** from the recent price of **C$1.125**. Forecasts are model-based projections and not guarantees.

CA Stocks

TMD.TO Titan Medical (TSX) jumps to C$1.13 on 20 Feb 2026: monitor volume surge

ByDanny Kontos February 20, 2026

TMD.TO stock led TSX intraday movers after a sharp volume spike sent Titan Medical Inc. to C$1.13 on 20 Feb 2026 from an open of C$0.05. The move reflected a large jump in trading activity with 117,220 shares traded versus an average volume of 45,936, a relative volume of 2.55. Intraday range ran from C$0.045 to C$1.13, and the price now sits well above its 50-day average of C$0.07, forcing traders to reassess liquidity and technical levels for this Toronto-listed healthcare device stock.